Consilient Health welcomes Non-Executive Director, Harald F. Stock PhD

Consilient Health is pleased to announce the appointment of Harald F. Stock PhD as Non-Executive Director of the Company.

Harald has worked in the industry for over 22 years. His extensive experience working with pharmaceuticals, diagnostics and medical devices compliments Consilient Health’s capabilities in a broad range of therapeutic areas.

Harald has worked within a variety of companies, developing and utilising his broad range of expertise. He has worked across Europe, the US, Asia-Pacific and Latin America. Harald has filled previous CEO and Presidential roles in companies including:

• OvaScience (NADAQ:OVAS), a biotechnology company
• ArjoHuntleigh AB, a medical equipment company
• Grünenthal, a privately held, international research-based pharmaceutical company;
• Chairman and Managing Director at DePoy International, the orthopaedics division of Johnson & Johnson.

Harald has also had various roles with Roche, including SVP in charge of the global Near Patient Testing business. He is currently Non-Executive Director of three other US and European healthcare companies.

Honoured and delighted

Harald states: “I am honoured and delighted to join Consilient Health’s Board. The Company’s unique business model and successful evolution has impressed me, and I am looking forward to working with the Board and Management in shaping the company’s path into an equally successful future.”

Consilient Health welcomes Harald to the Board and looks forward to benefiting from Harald’s extensive international experience and expertise.